LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • AstraZeneca PLC (LSE: AZN) Latest News

    Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
    Investing Articles

    Best British shares to buy in November

    We asked our writers to share their ‘best of British’ stocks to buy this month, including insurers and housebuilders.

    Read more »

    Young female analyst working at her desk in the office
    Investing Articles

    What on earth is going on with the AstraZeneca share price?

    Is recent weakness in the AstraZeneca share price a buying opportunity for me after 10 years of impressive performance?

    Read more »

    Female Doctor In White Coat Having Meeting With Woman Patient In Office
    Investing Articles

    6 super investors hold this FTSE 100 stock. Should I buy it too?

    Some world-renowned investors have selected this FTSE 100 stock for their mega-portfolios. But have their investments been lucrative and is…

    Read more »

    Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
    Investing Articles

    Down 10%, the most valuable stock on the FTSE 100 is starting to look cheap!

    Dr James Fox investigates whether the FTSE 100's most valuable stock, AstraZeneca, looks like a good buy after its 10%…

    Read more »

    Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
    Investing Articles

    2 FTSE 100 shares to buy in the UK stock market crash

    Following the mini budget, FTSE 100 shares took a beating as the index sank below 7,000. Our writer picks two…

    Read more »

    A young black man makes the symbol of a peace sign with two fingers
    Investing Articles

    2 no-brainer value stocks I think I’ll buy for Q4

    Jon Smith reveals two value stocks that he's thinking of buying to boost his portfolio performance as we go into…

    Read more »

    Female Doctor In White Coat Having Meeting With Woman Patient In Office
    Investing Articles

    If I’d invested £1,000 in AstraZeneca shares at the start of 2022, here’s what I’d have now

    AstraZeneca has been a top-performing FTSE 100 share in recent years. Roland Head wonders if this FTSE 100 pharma firm…

    Read more »

    Yellow number one sitting on blue background
    Investing Articles

    1 FTSE 100 stock that should continue to outperform long term

    The pharmaceutical company AstraZeneca is a FTSE 100 stock that stands out amongst Footsie companies for both its consistent growth…

    Read more »

    Question with the text “Top UK Blue-Chip Stocks” and The Motley Fool jester cap logo
    Page

    Investing in Blue-Chip Companies: Top UK Blue-Chip Stocks in 2022

    Blue-chip stocks are great portfolio builders. Here, we look at the top companies in the UK in terms of market…

    Read more »

    Arrow symbol glowing amid black arrow symbols on black background.
    Investing Articles

    Is this FTSE 100 pharma giant a growth stock in disguise?

    Growth stocks are companies that are expected to increase sales and earnings faster than the market average. But they're often…

    Read more »

    HEALTH in toy blocks with the text “Investing in Healthcare Top UK Healthcare Stocks” and The Motley Fool jester cap logo
    Page

    Investing in Healthcare: Top UK Healthcare Stocks in 2022

    Explore the top UK healthcare stocks delivering life-saving treatments and discover an explosive multi-trillion-dollar investment opportunity.

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    AstraZeneca shares fall after boosting guidance! Is this a buying opportunity?

    AstraZeneca shares were down around 2% in early morning trading despite registering positive results. So, what's going on here?

    Read more »